1 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Terminated 1 |
Follow Vulvar Adenocarcinoma: new trials by email Literature Review of Vulvar Adenocarcinoma trials Research Report on Vulvar Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors AVA6103 - Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma | Phase 1 | Recruiting | Avacta Life Sciences Ltd | 174 | 2026-03-31 | 2026-10-05 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer Biospecimen Collection, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ | Not applicable | Terminated | M.D. Anderson Cancer Center | 409 | 2014-10-27 | 2025-07-14 |
Uterine Cervical Neoplasms (2) · Vaginal Neoplasms (2) · Vulvar Neoplasms (2) · Colorectal Neoplasms (1) · Small Cell Lung Carcinoma (1) · Uterine Cervical Dysplasia (1)
Neoplasms (3) · Neoplasms by Site (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2) · Uterine Neoplasms (2) · Vaginal Diseases (2) · Vulvar Diseases (2) · Bronchial Neoplasms (1)
Disulfides (1) · Immunoglobulin G (1) · Radiosurgery (1) · durvalumab (1) · tremelimumab (1)
M.D. Anderson Cancer Center (2) · Avacta Life Sciences Ltd (1)
United States (3)
Kathleen Schmeler (1) · Lilie L Lin (1)